학술논문
Phase I trial of 131 I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients.
Document Type
Article
Author
D'Huyvetter, Matthias; De Vos, Jens; Caveliers, Vicky; Vaneycken, Ilse; Heemskerk, Johannes; Duhoux, Francois P.; Fontaine, Christel; Vanhoeij, Marian; Windhorst, Albert D.; van der Aa, Frank; Hendrikse, N. Harry; Eersels, Jos L. E.; Everaert, Hendrik; Gykiere, Pieterjan; Devoogdt, Nick; Raes, Geert; Lahoutte, Tony; Keyaerts, Marleen
Source
Journal of Nuclear Medicine; Dec2020, Vol. 61 Issue 12, p1-38, 38p
Subject
Language
ISSN
01615505